Clinical guidelines in the community pharmacy setting
Citation: Watkins K, Wood H, Schneider CR, et al. Effectiveness of implementation strategies for clinical guidelines to community pharmacy: a systematic review. Implementation Science 2015; 10: 151
What is this? The COVID-19 pandemic is placing a great strain on health systems. This is limiting access to health care for some people. Existing research on the delivery of healthcare services in community pharmacy settings may provide information for policy makers to help with this.
In this systematic review, the authors searched for research into strategies for implementing clinical guidelines in the community pharmacy setting. These included strategies aimed to influence the behaviour of pharmacists or other staff towards uptake and adherence of guideline-based practice. The authors restricted their searches to articles published in English and did their search in November 2014. They included 10 randomised trials, 3 non-randomised controlled trials, 1 controlled before-and-after study and 8 quasi-experimental or observational studies. Most (20 of the 22) included studies were rated as having low or very low quality of evidence for outcomes.
What was found: The implementation of clinical guidelines in the community pharmacy setting might be beneficial.
The implementation of clinical guidelines in the community pharmacy setting led to moderately positive benefits for process outcomes, but the effects on patient and economic outcomes are uncertain.
The best implementation strategies and the overall benefits of implementing clinical guidelines in the community pharmacy setting are uncertain.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.